On July 24, Philips Healthcare, Andover, Mass, announced that FDA has granted 510(k) clearance to market the company’s “ultra-mobile” ultrasound system, VISIQ, in the United States.
According to the company, a key component in the system is a smart transducer integrating broadband micro-digital beam former and an image acquisition module. In addition, the system’s touch-screen gesture controls allow users to capture images, take measurements, and share data. The system also includes many of the automatic image optimization features found on Philips’ EPIQ system, as well as built-in Wi-Fi for DICOM data transfer to hospital or cloud-based PACS
“VISIQ marks a new vision in ultrasound for Philips by allowing physicians to perform on-the-spot diagnostic scans, limiting the need for patients to go to multiple locations or schedule return visits,” said Gene Saragnese, CEO, Imaging Systems, Philips Healthcare. “VISIQ is the latest example of Philips’ continued commitment to create advanced innovative technology solutions to deliver better care at lower cost and to help improve patient outcomes.”